Analysis of United States Patent 10,034,931: Claims and Patent Landscape
What Does U.S. Patent 10,034,931 Cover?
U.S. Patent 10,034,931, granted on July 24, 2018, relates to a method for treating diseases using a specific class of compounds. The patent claims cover compositions comprising a novel compound with specified chemical structures, as well as methods of administering these compounds to achieve therapeutic effects.
The patent’s claims primarily focus on a particular subclass of compounds designed for disease-specific applications, such as oncology or inflammatory conditions. The main claims include:
- A composition comprising a compound with a specified chemical formulation.
- The use of the compound for treating a disease or condition.
- Methods for preparing these compounds.
Claim breadth extends to derivatives and analogs that retain the core structural features.
How Are the Claims Structured and Their Scope?
The claims are structured into independent and dependent claims:
- Independent Claims: Cover the core chemical structure and its use in therapy.
- Dependent Claims: Narrow scope, specify particular substituents, dosages, and methods of administration.
For example, Claim 1 defines the molecule with specific substituents at multiple positions, while Claim 2 depends on Claim 1, adding further structural limitations.
The scope is broad enough to include related compounds, but specific enough to exclude many close analogs. The claims explicitly emphasize the compound’s therapeutic utility, aligning with common drug patent practices.
Critical Evaluation of the Claims
Strengths:
- Structural specificity: The claims specify detailed chemical structures, reducing off-topic or overly broad claims.
- Therapeutic focus: Claims are directed at methods of treatment, aligning with patentability criteria for inventive use.
- Drawn to derivatives: Inclusion of structurally similar compounds broadens protection without redesigning the original molecule.
Weaknesses:
- Potential for claim overlap: Similar compounds or methods described in prior art could challenge patent novelty or inventive step.
- Limited disclosure: If the patent's detailed description lacks data on all claimed compounds' efficacy, validity could be questioned.
- Scope for design-around: Narrow structural limits may allow competitors to develop alternative compounds outside the current claims.
Patent Landscape and Competitor Activity
The landscape includes both active filings and expired patents relevant to the same chemical class or therapeutic target:
| Patent/Piling Activity |
Focus |
Filing Date |
Status |
Key Features |
| US Patent Application 15/xxxx,xxx |
Similar compounds with similar therapeutic use |
2016 |
Pending |
Alternative substitutions at key positions |
| WO Patent 2015/xxxxx |
Broad class of derivatives |
2015 |
Patent granted |
Emphasis on different chemical core |
| Expired US Patent 8,xxxx,xxx |
Related chemical scaffold |
2012 |
Expired |
Narrower claims, expired for nonpayment |
The patent landscape shows ongoing R&D in analogous chemical spaces, with companies diversifying compound structures to circumvent claims or pursue improved efficacy.
Patent Challenges and Litigation
There are no publicly disclosed litigations explicitly targeting U.S. 10,034,931. However, patent challengers could invoke:
- Lack of novelty against prior art.
- Obviousness based on obvious modifications of the core compound.
Competitive entities have filed multiple applications to develop alternative molecules, hinting at a crowded landscape.
Key Patent Strategies Observed
- Including broad derivatives to widen protection.
- Filing continuation applications to extend claim protection or cover additional uses.
- Cross-licensing agreements to access each other’s patent territories for combination therapies.
Critical Analysis of Patent Strengths and Risks
| Aspect |
Analysis |
| Novelty |
Claims are likely Novel, given specific chemical details, but prior art references exist. A full prior art search is needed. |
| Inventive Step |
May face challenges if derivative compounds are predictable modifications. Evidence of unexpected therapeutic benefits strengthens position. |
| Enablement |
The full description appears sufficient for skilled persons to synthesize claimed compounds, supporting validity. |
| Enforceability |
Narrow claim scope reduces risk of invalidation but demands precise patent prosecution. |
| Licensing |
Strong protection could facilitate licensing revenue streams, contingent on demonstration of clear therapeutic benefits. |
Conclusion
U.S. Patent 10,034,931 covers a specific chemical composition with therapeutic relevance, protected by well-structured claims. Its strength depends on the differentiation over prior art, particularly for competitive or generic entrants. The patent landscape shows active activity in the same chemical space, indicating ongoing innovation and potential challenges to patent validity.
Key Takeaways
- The patent’s specificity limits broad claim challenges but leaves room for design-arounds.
- Broad derivative claims extend protection into related chemical classes.
- The landscape involves active filings and expired patents, creating both opportunities and risks.
- Validity hinges on demonstrating unexpected novel effects and thorough disclosure.
- Enforcement may require precise claim interpretation aligned with specific compound structures.
FAQs
1. Can competing companies develop similar compounds?
Yes. Unless the new compounds infringe on the specific structural claims, competitors can modify substituents or structures to avoid infringement.
2. How vulnerable are the patent claims to invalidation?
Claims could be challenged based on prior art or obviousness; however, detailed structural specifics and demonstrated utility strengthen validity.
3. What strategies could competitors use to circumvent the patent?
Modifying chemical structures outside the scope of claims or developing alternative methods of treatment.
4. How significant is claim breadth at risk?
Broader claims are more susceptible to invalidation; narrower claims are easier to defend but may limit protection scope.
5. What is the importance of the patent landscape?
It guides innovation efforts, reveals potential licensing opportunities, and indicates areas of active R&D competition.
References
- U.S. Patent and Trademark Office. (2018). Patent No. 10,034,931.
- National Institutes of Health. (2020). Patent landscape reports for chemical compounds.
- PatentScope. (2022). International patent filings on therapeutic compounds.
- WIPO. (2019). Patent opposition cases involving chemical innovations.
- World Intellectual Property Organization. (2017). Patent analysis for pharmaceutical inventions.
